Aytu Biopharma (AYTU) Return on Capital Employed [ROCE] (2015 - 2026)
Aytu Biopharma's Return on Capital Employed [ROCE] was -15.49% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 2.68 percentage points from -12.80% a year earlier but up 11.17 percentage points from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Return on Capital Employed [ROCE] at Aytu Biopharma came in at -13.87%, down 0.40 percentage points from FY2025.
- Return on Capital Employed [ROCE] shows a five-year change of +44.97 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Capital Employed [ROCE] was -13.48% in FY2025 (-11.03 pp), -2.45% in FY2024 (+22.64 pp), -25.09% in FY2023 (+55.02 pp) and -80.10% in FY2022 (-21.26 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between -123.17% (fiscal Q4 2022) and 1.84% (fiscal Q3 2024) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for seven straight quarters, with an average year-over-year change of -4.80 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was fiscal Q4 2023 (a gain of 99.74 percentage points); the worst was fiscal Q4 2022 (a drop of 86.19 percentage points).
- Per Business Quant data, AYTU's Return on Capital Employed [ROCE] in the three fiscal quarters before Q4 2026 was -26.66% (Q3 2026), -14.98% (Q2 2026) and -14.34% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Aytu Biopharma | 22.49 Mn | -93.18 Mn | 10.41 Mn | -15.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.49% |
| Mar 31, 2026 | -26.66% |
| Dec 31, 2025 | -14.98% |
| Sep 30, 2025 | -14.34% |
| Jun 30, 2025 | -12.80% |
| Mar 31, 2025 | -5.00% |
| Dec 31, 2024 | -12.49% |
| Sep 30, 2024 | -2.97% |
| Jun 30, 2024 | -2.60% |
| Mar 31, 2024 | 1.84% |
| Dec 31, 2023 | -9.00% |
| Sep 30, 2023 | -23.30% |
| Jun 30, 2023 | -23.43% |
| Mar 31, 2023 | -58.01% |
| Dec 31, 2022 | -100.60% |
| Sep 30, 2022 | -118.21% |
| Jun 30, 2022 | -123.17% |
| Mar 31, 2022 | -100.45% |
| Dec 31, 2021 | -70.87% |
| Sep 30, 2021 | -55.82% |
API Access
Aytu Biopharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();